Kumar JG, Abhilash KPP, Saya RP, Tadipaneni N, Bose JM. A retrospective study on epidemiology of hypoglycemia in emergency department. Indian J Endocrinol Metab. 2017;21(1):119–24. https://pubmed.ncbi.nlm.nih.gov/ 28217510. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5240052. https://doi.org/10.4103/2230-8210.195993.

Munro V, McDonell LM, Keough V, Siddiqi FS. Insulinoma presenting as hypoglycemia during lactose tolerance testing: A case report. J Med Case Reports. 2020;14(1):96. https://pubmed.ncbi.nlm.nih.gov/ 32605595. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7325648. https://doi.org/10.1186/s13256-020-02419-4.

Okabayashi T, Shima Y, Sumiyoshi T, et al. Diagnosis and management of insulinoma. World J Gastroenterol. 2013;19(6):829–37. https://pubmed.ncbi.nlm.nih.gov/ 23430217. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3574879. https://doi.org/10.3748/wjg.v19.i6.829.

Salazar R, Wiedenmann B, Rindi G, Ruszniewski P. ENETS 2011 Consensus guidelines for the management of patients with digestive neuroendocrine tumors: An update. Neuroendocrinology. 2012;95(2):71–3. https://pubmed.ncbi.nlm.nih.gov/ 22262042. https://doi.org/10.1159/000335600.

Dauben L, Simon MC, Strassburger K, et al. Comparison of the diagnostic accuracy of the current guidelines for detecting insulinoma. Eur J Endocrinol. 2019;180(6):381–6. https://pubmed.ncbi.nlm.nih.gov/ 30991361. https://doi.org/10.1530/EJE-18-0879.

Cryer PE, Axelrod L, Grossman AB, et al. Evaluation and management of adult hypoglycemic disorders: An endocrine society clinical practice guideline. J Clin Endocrinol Metab. 2009;94(3):709–28. https://pubmed.ncbi.nlm.nih.gov/ 19088155. https://doi.org/10.1210/jc.2008-1410.

Liao J, Ding F, Luo W, Nie X, He Y, Li G. Using the secretion ratios of insulin and C-peptide during the 2-h oral glucose tolerance test to diagnose insulinoma. Dig Dis Sci. 2021;66(5):1533–9. https://pubmed.ncbi.nlm.nih.gov/32529519. https://doi.org/10.1007/s10620-020-06379-z.

Li X, Zhang F, Chen H, et al. Diagnosis of insulinoma using the ratios of serum concentrations of insulin and C-peptide to glucose during a 5-hour oral glucose tolerance test. Endocr J. 2017;64(1):49–57. https://pubmed.ncbi.nlm.nih.gov/ 27725372. https://doi.org/10.1507/endocrj.EJ16-0292.

Moher D, Liberati A, Tetzlaff J, Altman DG; PRISMA Group. Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement. PLoS Med. 2009;6(7):e1000097. https://pubmed.ncbi.nlm.nih.gov/19621072. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2707599. https://doi.org/10.1371/journal.pmed.1000097.